Capital Infusion into Cannabis Industry Operations for Product Development and Acquisitions Fueling Major Sector Growth Possibilities

Capital Infusion into Cannabis Industry Operations for Product Development and Acquisitions Fueling Major Sector Growth Possibilities

PR Newswire

PALM BEACH, Florida, December 5, 2016 /PRNewswire/ --

With the demand for legal marijuana & cannabis infused products quickly rising, industry operators are seeking capital funding opportunities to quickly develop new technology, products, acquire significant assets and resources to maximize operations, including plant growth.  Cannabis operators in the markets this week include:  Marapharm Ventures Inc. (OTCQB: MRPHF), MassRoots, Inc. (OTCQB: MSRT), GW Pharmaceuticals plc (NASDAQ: GWPH), Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) and Terra Tech Corp. (OTCQX: TRTC)

Marapharm Ventures Inc. (OTCQB: MRPHF) announces that it is paying the Nevada Title, Escrow Agent, for full payment and discharge of the first mortgage financing on 5.9 acres located in Apex Industrial Park, Las Vegas, Nevada. In addition Marapharm is paying cash without debt for the previously announced addition of 1.1 adjoining acres.

"We've received several million dollars recently from warrants being exercised by loyal shareholders with more coming in daily, and we decided to pay off our debt, which is this one mortgage. We paid $445,500 USD for the property and financed $309,000. In addition we paid taxes and fees and posted about $100,000 for wet and dry utility bonds. We've also done improvements on the site and have invested more than $100,000 on site and facilities planning. And we've paid for buildings that are to be delivered within 3 weeks and erected for cultivation. The monthly mortgage payments were $2,785.22," said Linda Sampson, Marapharm CEO and she added, "Paying off a relatively small mortgage and paying $110,000 cash for the 1.1 acres may not sound like a big deal but to us the significance is that we did what we planned to do in terms of reaching our milestones."  Read the full Marapharm press release and other news at:

"With more than 50 million adult visitors each year, Las Vegas is the known as the best cannabis play in the world. Marapharm chose Las Vegas and Nevada for its model and for a place we wanted to be for doing business. There's no state corporate income tax, there's no personal income tax, there's City tax concessions, there's excellent State incentives and we are located in a logistical hub of 11 state regions. Further there's an educated and cost effective workforce and a superior telecommunications infrastructure. So we believe that we are in the right place at the right time," says Linda Sampson. Marapharm CEO.

In other cannabis industry news and performances of note:

MassRoots, Inc. (OTCQB: MSRT) closed up over 4% on Friday at $0.73 trading just over 470,000 shares by the market close.  MassRoots operates a technology platform for the cannabis community in the United States. The company’s mobile network enables users to share cannabis content to connect with the legalization movement.

GW Pharmaceuticals plc (NASDAQ: GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced late last week results from two completed Epidiolex® (cannabidiol or CBD) Phase 3 trials, one in Lennox-Gastaut syndrome (LGS) and one in Dravet syndrome (DS), will be presented at the American Epilepsy Society (AES) Annual Meeting, December 2-6, 2016, in Houston, Texas.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced last Thursday that results from the company's Cancer HTS research indicates that specific ratios of Cannabinoids led to Apoptosis in MDA-MB-231 Breast Cancer cell viability. Cannabics Pharmaceuticals is currently developing a personalized treatment based upon screening of patients' biopsy and delivering specified cannabinoid medicine which contains anti-tumor properties. It is believed this technology will enable oncologist and other treating physicians to provide cancer patients with a personalized anti-cancer cannabinoid based therapy.

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, announced on Friday that Terra Tech subsidiary, Edible Garden, will participate in the New York Produce Show and Conference December 7th. Edible Garden will showcase its organic SUPERLEAF™ product along with organic herbs at the one-day industry trade show of over 400 companies that includes local retailers, wholesalers, foodservice distributors, urban farms and unique eateries. This is the only produce show in New York City and is the 2nd largest produce trade show in North America. The attendee make-up for this event is over 40% buyers with over 5,000 produce executives from around the world visiting the 400 exhibitors for 1-on-1 meetings.

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  MNU is NOT affiliated in any manner with any company mentioned herein.  MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Marapharm Ventures Inc.  by a non-affiliated third party.  MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:

Media Contact email:  [email protected]   - +1-561-325-8757


Copyright CNW Group 2016